Aclaris Therapeutics, Inc. (33) | Human Resources (17)

Browse by Subcategory

Recent Contracts

Seventh Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 24, 2022)
Severance Agreement and General Release, dated as of January 7, 2022, by and between the Registrant and David Gordon (Filed With SEC on February 24, 2022)
Employment Agreement, dated as of January 31, 2022, by and between the Registrant and James Loerop (Filed With SEC on February 24, 2022)
Change in Control Severance Benefit Plan, effective January 1, 2017, as amended by First Amendment to Change in Control Severance Benefit Plan, effective October 2, 2019 (Filed With SEC on February 25, 2021)
Form of Performance Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement used in connection with the 2015 Equity Incentive Plan (Filed With SEC on March 18, 2019)
Severance Agreement and General Release, dated as of November 1, 2021, by and between the Registrant and Kamil Ali-Jackson (Filed With SEC on February 24, 2022)
Employment Agreement, dated as of January 12, 2022, by and between the Registrant and Joseph Monahan (Filed With SEC on February 24, 2022)
Sixth Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 24, 2022)
Amended and Restated Employment Agreement, dated as of January 12, 2022, by and between the Company and Neal Walker (Filed With SEC on January 14, 2022)
Amended and Restated Employment Agreement, dated as of January 12, 2022, by and between the Company and Frank Ruffo (Filed With SEC on January 14, 2022)
Fifth Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on August 5, 2021)
Fourth Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 25, 2021)
Employment Agreement with Frank Ruffo, dated as of September 17, 2015 (Filed With SEC on February 25, 2020)
Third Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 25, 2020)
Second Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 25, 2020)
Amended & Restated Non-Employee Director Compensation Policy (Filed With SEC on March 18, 2019)
Form of Performance Stock Option Grant Notice and Stock Option Agreement used in connection with the 2015 Equity Incentive Plan (Filed With SEC on March 18, 2019)